ArticleCancer management and research2018

Efficacy and safety of crizotinib in patients with anaplastic lymphoma kinase-positive advanced-stage non-small-cell lung cancer.

Ahmed Mohieldin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.